93 related articles for article (PubMed ID: 17169354)
1. Role of TGF-beta1 in vascular smooth muscle cell apoptosis induced by angiotensin II.
Redondo S; Ruiz E; Padilla E; Gordillo-Moscoso A; Tejerina T
Eur J Pharmacol; 2007 Feb; 556(1-3):36-44. PubMed ID: 17169354
[TBL] [Abstract][Full Text] [Related]
2. Importance of intracellular angiotensin II in vascular smooth muscle cell apoptosis: inhibition by the angiotensin AT1 receptor antagonist irbesartan.
Ruiz E; Redondo S; Padilla E; Gordillo-Moscoso A; Salaices M; Balfagón G; Tejerina T
Eur J Pharmacol; 2007 Jul; 567(3):231-9. PubMed ID: 17509562
[TBL] [Abstract][Full Text] [Related]
3. Pioglitazone induces apoptosis in human vascular smooth muscle cells from diabetic patients involving the transforming growth factor-beta/activin receptor-like kinase-4/5/7/Smad2 signaling pathway.
Ruiz E; Redondo S; Gordillo-Moscoso A; Tejerina T
J Pharmacol Exp Ther; 2007 May; 321(2):431-8. PubMed ID: 17267584
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin II upregulates transforming growth factor-beta type I receptor on rat vascular smooth muscle cells.
Fukuda N; Hu WY; Kubo A; Kishioka H; Satoh C; Soma M; Izumi Y; Kanmatsuse K
Am J Hypertens; 2000 Feb; 13(2):191-8. PubMed ID: 10701820
[TBL] [Abstract][Full Text] [Related]
5. FK506 can activate transforming growth factor-beta signalling in vascular smooth muscle cells and promote proliferation.
Giordano A; Romano S; Mallardo M; D'Angelillo A; Calì G; Corcione N; Ferraro P; Romano MF
Cardiovasc Res; 2008 Aug; 79(3):519-26. PubMed ID: 18349138
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor beta1 mediates apoptotic activity of angiotensin II type I receptor blocker on prostate epithelium in vitro.
Zhao Y; Peng J; Zheng L; Yu W; Jin J
Prostate; 2010 Jun; 70(8):899-905. PubMed ID: 20135646
[TBL] [Abstract][Full Text] [Related]
7. AT1 antagonist modulates activin-like kinase 5 and TGF-beta receptor II in the developing kidney.
Yim HE; Kim MK; Bae IS; Kim JH; Choi BM; Yoo KH; Hong YS; Lee JW
Pediatr Nephrol; 2006 Oct; 21(10):1377-88. PubMed ID: 16897002
[TBL] [Abstract][Full Text] [Related]
8. TGF-beta inhibits Ang II-induced MAPK p44/42 signaling in vascular smooth muscle cells by Ang II type 1 receptor downregulation.
Meijering BD; van der Wouden EA; Pelgröm V; Henning RH; Sharma K; Deelman LE
J Vasc Res; 2009; 46(5):459-68. PubMed ID: 19204403
[TBL] [Abstract][Full Text] [Related]
9. Regulation of discoidin domain receptor 2 by cyclic mechanical stretch in cultured rat vascular smooth muscle cells.
Shyu KG; Chao YM; Wang BW; Kuan P
Hypertension; 2005 Sep; 46(3):614-21. PubMed ID: 16087782
[TBL] [Abstract][Full Text] [Related]
10. Tgf-beta1 induced by high glucose is controlled by angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker on cultured human peritoneal mesothelial cells.
Kyuden Y; Ito T; Masaki T; Yorioka N; Kohno N
Perit Dial Int; 2005; 25(5):483-91. PubMed ID: 16178483
[TBL] [Abstract][Full Text] [Related]
11. Systemic and local effects of angiotensin II blockade in experimental diabetic nephropathy.
Vieitez P; Gómez O; Uceda ER; Vera ME; Molina-Holgado E
J Renin Angiotensin Aldosterone Syst; 2008 Jun; 9(2):96-102. PubMed ID: 18584585
[TBL] [Abstract][Full Text] [Related]
12. Involvement of transforming growth factor-beta in regulation of calcium transients in diabetic vascular smooth muscle cells.
Sharma K; Deelman L; Madesh M; Kurz B; Ciccone E; Siva S; Hu T; Zhu Y; Wang L; Henning R; Ma X; Hajnoczky G
Am J Physiol Renal Physiol; 2003 Dec; 285(6):F1258-70. PubMed ID: 12876066
[TBL] [Abstract][Full Text] [Related]
13. Effect of angiotensin II and angiotensin II type 1 receptor antagonist on the proliferation, contraction and collagen synthesis in rat hepatic stellate cells.
Liu J; Gong H; Zhang ZT; Wang Y
Chin Med J (Engl); 2008 Jan; 121(2):161-5. PubMed ID: 18272044
[TBL] [Abstract][Full Text] [Related]
14. Autocrine TGF-beta1 mediates angiotensin II-induced proliferative response of cerebral vessels in vivo.
Yurovsky VV; Gerzanich V; Ivanova S; Dong Y; Tsymbalyuk O; Simard JM
Am J Hypertens; 2007 Sep; 20(9):950-6. PubMed ID: 17765135
[TBL] [Abstract][Full Text] [Related]
15. Stretch-induced collagen synthesis in cultured smooth muscle cells from rabbit aortic media and a possible involvement of angiotensin II and transforming growth factor-beta.
Li Q; Muragaki Y; Hatamura I; Ueno H; Ooshima A
J Vasc Res; 1998; 35(2):93-103. PubMed ID: 9588872
[TBL] [Abstract][Full Text] [Related]
16. Involvement of profilin-1 in angiotensin II-induced vascular smooth muscle cell proliferation.
Cheng JF; Ni GH; Chen MF; Li YJ; Wang YJ; Wang CL; Yuan Q; Shi RZ; Hu CP; Yang TL
Vascul Pharmacol; 2011; 55(1-3):34-41. PubMed ID: 21586339
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II-induced differentiation of adipose tissue-derived mesenchymal stem cells to smooth muscle-like cells.
Kim YM; Jeon ES; Kim MR; Jho SK; Ryu SW; Kim JH
Int J Biochem Cell Biol; 2008; 40(11):2482-91. PubMed ID: 18571460
[TBL] [Abstract][Full Text] [Related]
18. Negative regulation of local hepatocyte growth factor expression by angiotensin II and transforming growth factor-beta in blood vessels: potential role of HGF in cardiovascular disease.
Nakano N; Morishita R; Moriguchi A; Nakamura Y; Hayashi SI; Aoki M; Kida I; Matsumoto K; Nakamura T; Higaki J; Ogihara T
Hypertension; 1998 Sep; 32(3):444-51. PubMed ID: 9740609
[TBL] [Abstract][Full Text] [Related]
19. Effects of BAY 10-6734 (Embusartan), a new angiotensin II type I receptor antagonist, on vascular smooth muscle cell growth.
Iouzalen L; Stepien O; Marche P
J Pharmacol Exp Ther; 1999 Apr; 289(1):181-7. PubMed ID: 10087002
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor-beta1 is associated with kidney damage in patients with essential hypertension: renoprotective effect of ACE inhibitor and/or angiotensin II receptor blocker.
Zhu S; Liu Y; Wang L; Meng QH
Nephrol Dial Transplant; 2008 Sep; 23(9):2841-6. PubMed ID: 18390891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
